{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T03:15:08Z","timestamp":1771038908835,"version":"3.50.1"},"reference-count":19,"publisher":"American Academy of Pediatrics (AAP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,2,1]]},"abstract":"<jats:p>Serotonergic medications are used for the prevention and treatment of depression during pregnancy. Selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors (SNRIs) can cause poor neonatal adaptation, which has been attributed to withdrawal versus toxicity. Bupropion, a norepinephrine-dopamine reuptake inhibitor, is often used as an adjunctive agent to selective serotonin reuptake inhibitors or SNRIs for refractory depression. Quetiapine, an atypical antipsychotic, may also be used in more complex cases. When combined with serotonergic drugs, bupropion and quetiapine are associated with increased risk of serotonin syndrome in adults. We describe a neonate exposed to venlafaxine (an SNRI), bupropion, and quetiapine in utero who presented nearly immediately after birth with encephalopathy and abnormal movements. The severity and rapidity of symptoms may be attributable to potentiation of venlafaxine\u2019s serotonergic effects by bupropion and quetiapine. Neonatal providers should be aware of maternal medications and prepare for possible adverse effects, particularly from common psychotropic exposures.<\/jats:p>","DOI":"10.1542\/peds.2019-2250","type":"journal-article","created":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T09:26:24Z","timestamp":1611739584000},"source":"Crossref","is-referenced-by-count":10,"title":["Why the Maternal Medication List Matters: Neonatal Toxicity From Combined Serotonergic Exposures"],"prefix":"10.1542","volume":"147","author":[{"given":"Michelle R.","family":"Brajcich","sequence":"first","affiliation":[{"name":"University of Colorado School of Medicine, Aurora, Colorado; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauricio A.","family":"Palau","sequence":"additional","affiliation":[{"name":"University of Colorado School of Medicine, Aurora, Colorado; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricka D.","family":"Messer","sequence":"additional","affiliation":[{"name":"Children\u2019s Hospital Colorado, Aurora, Colorado"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael E.","family":"Murphy","sequence":"additional","affiliation":[{"name":"Children\u2019s Hospital Colorado, Aurora, Colorado"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill","family":"Marks","sequence":"additional","affiliation":[{"name":"Children\u2019s Hospital Colorado, Aurora, Colorado"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2021,2,1]]},"reference":[{"issue":"5","key":"2021121013252592000_B1","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1053\/j.semperi.2008.08.001","article-title":"Fetal and neonatal effects of maternal drug treatment for depression","volume":"32","author":"Belik","year":"2008","journal-title":"Semin Perinatol"},{"issue":"2","key":"2021121013252592000_B2","first-page":"127","article-title":"A systematic review of maternal antidepressant use in pregnancy and short- and long-term offspring\u2019s outcomes","volume":"21","author":"Prady","year":"2018","journal-title":"Arch Women Ment Health"},{"issue":"3","key":"2021121013252592000_B3","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.genhosppsych.2012.12.010","article-title":"National trends in antidepressant medication treatment among publicly insured pregnant women","volume":"35","author":"Huybrechts","year":"2013","journal-title":"Gen Hosp Psychiatry"},{"issue":"2","key":"2021121013252592000_B4","doi-asserted-by":"crossref","first-page":"194.e1","DOI":"10.1016\/j.ajog.2007.07.036","article-title":"Use of antidepressant medications during pregnancy: a multisite study","volume":"198","author":"Andrade","year":"2008","journal-title":"Am J Obstet Gynecol"},{"issue":"11","key":"2021121013252592000_B5","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1542\/pir.2017-0201","article-title":"Effect of maternal substance abuse on the fetus, neonate, and child","volume":"39","author":"Bailey","year":"2018","journal-title":"Pediatr Rev"},{"issue":"2","key":"2021121013252592000_B6","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ejpn.2016.11.003","article-title":"Neonatal venlafaxine discontinuation syndrome: a mini-review","volume":"21","author":"Holland","year":"2017","journal-title":"Eur J Paediatr Neurol"},{"issue":"2","key":"2021121013252592000_B7","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1001\/archpedi.160.2.173","article-title":"Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants","volume":"160","author":"Levinson-Castiel","year":"2006","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"7","key":"2021121013252592000_B8","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1001\/archpsyc.60.7.720","article-title":"Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations","volume":"60","author":"Laine","year":"2003","journal-title":"Arch Gen Psychiatry"},{"issue":"2","key":"2021121013252592000_B9","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s13181-010-0021-x","article-title":"Bupropion induced serotonin syndrome: a case report","volume":"6","author":"Thorpe","year":"2010","journal-title":"J Med Toxicol"},{"issue":"8","key":"2021121013252592000_B10","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1017\/S1092852900021386","article-title":"Serotonin syndrome in elderly patients treated for psychotic depression with atypical antipsychotics and antidepressants: two case reports","volume":"12","author":"Kohen","year":"2007","journal-title":"CNS Spectr"},{"issue":"2","key":"2021121013252592000_B11","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s13181-010-0131-5","article-title":"Frequency of false positive amphetamine screens due to bupropion using the Syva EMIT II immunoassay","volume":"7","author":"Casey","year":"2011","journal-title":"J Med Toxicol"},{"issue":"5","key":"2021121013252592000_B12","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/01.wnf.0000142754.46045.8c","article-title":"Serotonin syndrome induced by a combination of bupropion and SSRIs","volume":"27","author":"Munhoz","year":"2004","journal-title":"Clin Neuropharmacol"},{"key":"2021121013252592000_B13","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.pnpbp.2018.04.014","article-title":"Reduced clearance of venlafaxine in a combined treatment with quetiapine","volume":"85","author":"Paulzen","year":"2018","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"3","key":"2021121013252592000_B14","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1055\/s-0028-1103296","article-title":"Placental transfer of SSRI and SNRI antidepressants and effects on the neonate","volume":"42","author":"Rampono","year":"2009","journal-title":"Pharmacopsychiatry"},{"issue":"4","key":"2021121013252592000_B15","first-page":"262","article-title":"Developmental pharmacokinetics in pediatric populations","volume":"19","author":"Lu","year":"2014","journal-title":"J Pediatr Pharmacol Ther"},{"issue":"1","key":"2021121013252592000_B16","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40348-016-0068-0","article-title":"Renal consequences of preterm birth","volume":"4","author":"Stritzke","year":"2017","journal-title":"Mol Cell Pediatr"},{"key":"2021121013252592000_B17","author":"Wellbutrin (Bupropion Hydrochloride) Tablets [Package Insert]","year":"2009"},{"key":"2021121013252592000_B18","author":"Seroquel (Quetiapine Fumarate) Tablets [Package Insert]","year":"2003"},{"key":"2021121013252592000_B19","article-title":"Neonatal seizures and neonatal syndromes","volume-title":"The Epilepsies: Seizures, Syndromes and Management","author":"Panayiotopoulos","year":"2005"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2019-2250\/1082203\/peds_20192250.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2019-2250\/1082203\/peds_20192250.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,11]],"date-time":"2021-12-11T02:41:47Z","timestamp":1639190507000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/147\/2\/e20192250\/36230\/Why-the-Maternal-Medication-List-Matters-Neonatal"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,1]]},"references-count":19,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,2,1]]},"published-print":{"date-parts":[[2021,2,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2019-2250","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,1]]},"article-number":"e20192250"}}